Video

Will There Be Hesitancy to Prescribe Biosimilars?

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

This video was recorded at the 2015 NACDS Total Store Expo.

Related Videos
Related Content
Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination
December 21st 2024

Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination

Aislinn Antrim, Assistant Managing Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

HIV test strip | Image Credit: © Mulin - stock.adobe.com
December 21st 2024

FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding Access to Adolescents

Alexandra Gerlach, Associate Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
FDA Approval, Weight Loss, Pediatrics | Image Credit: Aquir | stock.adobe.com
December 20th 2024

FDA Approves Expanded Indication for Setmelanotide to Include Patients 2 and Older

Ashley Gallagher, Associate Editor
Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor